OCUL Stock Performance and Key Statistics
Ocular Therapeutix, Inc.
OCUL stock performance chart
Ocular Therapeutix
The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism. However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators. Comparing their expectations to the market could help investors estimate their prospective return.
OCUL Fundamental Analysis
OCUL Performance Chart
OCUL Technical Analysis
Performance
Period
High
Low
Performance
1 Week1 MonthQuarterHalf Year1 YearYTD8.439.2211.7811.7811.789.227.77.77.76.943.927.7-2.44%-10.80%-30.10%+3.35%+93.01%-6.21%OCUL Industry Analysis and Valuation
Frequently Asked Questions
OCUL has a current P/E ratio of -7.72
The OCUL stock has a trailing twelve month price-to sales (P/S) ratio of 20.63 while its price-to-book (P/B) value is 3.82.
OCUL's price-to-free-cashflow (P/FCF) ratio is -11.1, an indicator that is currently being trending upward.
Based on OCUL's recent bid, its distance from 20 days simple moving average is -3.98%. It is -11.1% apart from 50 days simple moving average, and it is 0.13% apart from 200 days simple moving average.
The 52-week high for OCUL is $11.78 which is -31.3% away from the current price level whereas the distance of that from the 52-week low of $3.92 stands at 115.17%.
The performance of OCUL stock was not encouraging with most of its significant price indicators in red. Ocular Therapeutix, Inc.(NASDAQ: OCUL) shares have moved upward +1.00% or $0.08 in the latest trading session and have lost -6.21% year-to-date (YTD). The stock has gained nearly 93.01% over the past year. After moving -30.1% over the trailing 3-month period, the stock is 3.35% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -2.44% a week and -10.8% a month.
The current 14-day RSI for OCUL stock is 40.09. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Ocular Therapeutix, Inc. (OCUL) has a 14-day ATR of 0.42.
After closing at $8.01 with 157.22M of its shares outstanding, the current enterprise value of OCUL is roughly 577.8M.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is up 93.01% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 24.99%. OCUL stock price is also down -6.21% on its value in year-to-date trading.
The number outstanding shares of OCUL is 157.22M, and of these 86.28% shares are freely available for trading. On average, OCUL stock has traded 742.53K shares per day for the past 10 days. A total of 541.37K shares changed hands during the last trading session with the average session volume of 892.55K shares.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com